Disclosure of Payments to Healthcare Professionals

Our collaborations with healthcare professionals always aim to benefit patients, improve medical practices and patient care. 
Activities can range from clinical research to exchanges on how new medicines fit into patient pathway. 
We believe that a more open transparent relationship strengthens the basis for collaboration and is in the best interest of patients and all health stakeholders.
For this reason, we are committed to disclose our interactions with healthcare professionals and organizations through the Disclosure Code de l’EFPIA.

Austria

Public disclosure   202020212022

 

Belgium

Public disclosure EFPIA PF BENELUX  2022

Public disclosure PF health BENELUX 2022

Public disclosure PF corporate BENELUX 2022

No Transfer of Value in 2020,2021

 

Bulgaria

Public disclosure 202020212022

 

Cyprus

Public disclosure  20212022
No Transfer of Value in 2020

 

Czech Republic 

Public disclosure   202020212022

 

Denmark

Public disclosure  202020212022

 

Estonia

No Transfer of Value in 2020, 2021, 2022

 

Finland

Public disclosure  202020212022

 

France

 

Germany

 

Greece

 

Report PFD 2020/Report PFD 2021/Report PFD 2022

PFMS Italy Greek Crossborder 2020 /Pierre Fabre Corporate Greek Crossborder 2020/Pierre Fabre Greek Crossborder ToVs 2021/ Pierre Fabre Corporate Greek Crossborder 2022

Report PFMS 2020/Report PFMS 2021/Report PFMS 2022/

 

 

Hungary

Public disclosure  20212022
No Transfer of Value in 2020

 

Italy

 

Irlande

 

Lithuania


No Transfer of Value in  2020, 2021, 2022

 

Luxembourg

Public disclosure  2022

No transfer of Value in 2020, 2021,

 

Malta

No Transfer of Value in 2020, 2021, 2022

 

Netherlands 

 

Norway

Public disclosure  202020212022

 

Poland

Public disclosure HCP      202020212022
Public disclosure  HCO   202020212022
Public disclosure R&D     202020212022

 

Portugal


Romania

No Transfer of Value in  2020, 2021, 2022

 

Slovak republic

Public disclosure  202020212022

 

Spain


Sweden

Public disclosure  202020212022


Switzerland

Public disclosure  202020212022

 

Ukraine

No Transfer of Value in 2020, 2021, 2022
 

United Kingdom



 

DISCLOSURE METHODOLOGY PIERRE FABRE PHARMACEUTICALS TOV 2023

 

We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.